Translational Development Acquisition earnings were $5.5M for the trailing 12 months ending Jun 30, 2026, with 108.3% growth year over year. The latest TDAC earnings report on Jun 30, 2026 announced Q2 2026 earnings of $947.0k, down 28.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TDAC reported annual earnings of $6.4M, with -9,059.7% growth.
TDAC past earnings growth
How has TDAC's earnings growth performed historically?
Translational Development Acquisition Earnings Reports & History FAQ
What were Translational Development Acquisition's earnings last quarter?
Translational Development Acquisition (NASDAQ: TDAC) reported Q2 2026 earnings per share (EPS) of $0.04, up 42.86% year over year. Total TDAC earnings for the quarter were $946.98 thousand. In the same quarter last year, Translational Development Acquisition's earnings per share (EPS) was $0.07.
Is Translational Development Acquisition profitable or losing money?
As of the last Translational Development Acquisition earnings report, Translational Development Acquisition is currently profitable. Translational Development Acquisition's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $5.54 million, a 82.27% increase year over year.
What was TDAC's earnings growth in the past year?
As of Translational Development Acquisition's earnings date in Q3 2026, Translational Development Acquisition's earnings has grown 108.33% year over year. This is 57.02 percentage points higher than the US Shell Companies industry earnings growth rate of 51.32%. TDAC earnings in the past year totalled $5.54 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.